US government challenges jury decision in Gilead HIV patent trial

The US government has asked a Delaware federal court to reverse a recent jury decision favoring Gilead in the parties’ long-running HIV drug patent battle.

The case traces back to a complaint filed in 2019 alleging Gilead’s growing HIV pre-exposure prophylaxis (PrEP) franchise benefited from the CDC’s “groundbreaking PrEP work”…